186 related articles for article (PubMed ID: 23880719)
1. Reduced-dose carboxypeptidase-G2 successfully lowers elevated methotrexate levels in an adult with acute methotrexate-induced renal failure.
Trifilio S; Ma S; Petrich A
Clin Adv Hematol Oncol; 2013 May; 11(5):322-3. PubMed ID: 23880719
[No Abstract] [Full Text] [Related]
2. Using a lower dose of glucarpidase to reduce plasma levels of methotrexate.
Widemann BC
Clin Adv Hematol Oncol; 2013 May; 11(5):324-5. PubMed ID: 23880720
[No Abstract] [Full Text] [Related]
3. [Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure].
von Poblozki A; Dempke W; Schmoll HJ
Med Klin (Munich); 2000 Aug; 95(8):457-60. PubMed ID: 10985069
[TBL] [Abstract][Full Text] [Related]
4. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
Tuffaha HW; Al Omar S
J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
[TBL] [Abstract][Full Text] [Related]
5. Fixed-Dose Glucarpidase for Toxic Methotrexate Levels and Acute Kidney Injury in Adult Lymphoma Patients: Case Series.
Truong H; Leung N
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e497-e502. PubMed ID: 33563580
[No Abstract] [Full Text] [Related]
6. Reply to: Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion.
Widemann BC
Pediatr Blood Cancer; 2016 Feb; 63(2):366. PubMed ID: 26488622
[No Abstract] [Full Text] [Related]
7. Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion.
Meyers PA
Pediatr Blood Cancer; 2016 Feb; 63(2):364. PubMed ID: 26488216
[No Abstract] [Full Text] [Related]
8. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC
Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809
[TBL] [Abstract][Full Text] [Related]
10. What is the best therapy for toxicity in the setting of methotrexate-associated acute kidney injury: high-flux hemodialysis or carboxypeptidase G2?
Kumar N; Shirali AC
Semin Dial; 2014; 27(3):226-8. PubMed ID: 24620824
[No Abstract] [Full Text] [Related]
11. Reply to: Glucarpidase for the Treatment of Methotrexate-Induced Renal Dysfunction and Delayed Methotrexate Excretion.
Scott JR; Crews KR
Pediatr Blood Cancer; 2016 Feb; 63(2):365. PubMed ID: 26488798
[No Abstract] [Full Text] [Related]
12. Methotrexate nephrotoxicity: Novel treatment, new approach.
Iqbal S; Armaghani A; Aiyer R; Kazory A
J Oncol Pharm Pract; 2013 Dec; 19(4):373-6. PubMed ID: 24255083
[TBL] [Abstract][Full Text] [Related]
13. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels.
Wyatt KD; Cooper J; Scott K; Broomall E; Altaf S; Hogan MC; Rodriguez V; Khan S
J Pediatr Hematol Oncol; 2018 Mar; 40(2):152-155. PubMed ID: 29240024
[TBL] [Abstract][Full Text] [Related]
14. Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction.
Widemann BC
Pediatr Blood Cancer; 2015 Sep; 62(9):1512-3. PubMed ID: 25940351
[No Abstract] [Full Text] [Related]
15. Acute methotrexate neurotoxicity revealed by a cerebellar syndrome.
Zahra K; Bouneb R; Mahjoub M; Zaghouani H; Zaier M; Ben Youssef Y; Khelif A
Rev Neurol (Paris); 2016 Dec; 172(12):791-793. PubMed ID: 27773447
[No Abstract] [Full Text] [Related]
16. Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Nowicki TS; Bjornard K; Kudlowitz D; Sandoval C; Jayabose S
J Pediatr Hematol Oncol; 2008 Dec; 30(12):950-2. PubMed ID: 19131789
[TBL] [Abstract][Full Text] [Related]
17. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
[TBL] [Abstract][Full Text] [Related]
18. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients.
Scott JR; Zhou Y; Cheng C; Ward DA; Swanson HD; Molinelli AR; Stewart CF; Navid F; Jeha S; Relling MV; Crews KR
Pediatr Blood Cancer; 2015 Sep; 62(9):1518-22. PubMed ID: 25631103
[TBL] [Abstract][Full Text] [Related]
19. Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure.
Krackhardt A; Schwartz S; Korfel A; Thiel E
Leuk Lymphoma; 1999 Nov; 35(5-6):631-5. PubMed ID: 10609804
[TBL] [Abstract][Full Text] [Related]
20. [Acute toxicity of high doses of methotrexate in treatment of ALL in children: a case study].
Periáñez-Párraga L; Pérez-Rodríguez O; do Pazo-Oubiña F; Crespí-Monjo M
Farm Hosp; 2009; 33(3):172-3. PubMed ID: 19712601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
